$NVCC PR uptick $3.45 called 7/20/13 $0.99 h
Post# of 136
called 7/20/13 $0.99
Website
NanoViricides Reports Novel Drug Candidates for Treatment of the MERS
(Middle East Respiratory Syndrome) Corona Virus Ready for Animal Testing
news release
recent trades
Stockwatch
10-Q 2/14/14
O/S shares 53,957,000
Nasdaq
NanoViricides Reports Novel Drug Candidates for Treatment
of the MERS (Middle East Respiratory Syndrome)
Corona Virus Ready for Animal Testing
5/5/2014 7:00:00 AM - Business Wire
Friday Sector Laggards: Biotechnology, Construction Materials & Machinery Stocks
4/25/2014 2:56:33 PM - BNK Invest
NanoViricides Won the IAIR AWARD
as Best North American Company for Leadership in the Nanomedicine Sector
4/16/2014 8:43:00 AM - Business Wire
3 Stocks To Profit From The Cutting-Edge Vaccine Market
4/7/2014 8:30:00 AM - Investopedia
This Biotech Market Could Quadruple -- 3 Stocks To Profit
4/7/2014 8:30:00 AM - Investopedia
% Buy Opinion (composite)